Key statistics
On Friday, Bicycle Therapeutics PLC (50BA:STU) closed at 4.34, 0.93% above its 52-week low of 4.30, set on Feb 12, 2026.
52-week range
| Open | 4.40 |
|---|---|
| High | 4.54 |
| Low | 4.34 |
| Bid | 4.36 |
| Offer | 4.50 |
| Previous close | 4.42 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 69.37m |
| Free float | 4.33m |
| P/E (TTM) | -- |
| Market cap | 363.49m USD |
| EPS (TTM) | -3.62 USD |
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Press releases
- Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline
- Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
- Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline
- Ankyra Appoints Sailaja Battula, PhD as Chief Scientific Officer (CSO)
- Cassidy Bio Launches with the Goal to Develop Safer, More Scalable Gene Editing Therapies
More ▼
